O.A. Egorova (1, 2)1) Smolensk State Medical University, Smolensk, Russia; 2) Smolensk Regional Clinical Hospital, Smolensk, Russia
Roxithromycin is a classic representative of 14-membered macrolides and has a number of clinically significant therapeutic features. Pharmacodynamic and pharmacokinetic properties of roxithromycin in combination with high safety have been confirmed in numerous clinical studies. The high efficacy of the antibiotic, regardless of the frequency of its administration, makes it possible to widely use roxithromycin in the treatment of infections in both adults and children.
For citations: Egorova O.A. Macrolide antibiotic roxitromycin – the main clinical and pharmacological aspects of application. Farmateka. 2019;26(5):29–38. (in Russian). DOI: https://dx.doi.org/10.18565/pharmateca.2019.5.29-38
Corresponding author: Ola A. Egorova, PhD, Teaching Assistant at the Department of Otorhinolaryngology, Smolensk State Medical University, Head of the Children’s Otorhinolaryngological Department at the Smolensk Regional Clinical Hospital, Smolensk, Russia; e-mail: Olaemail@example.com
Address: 38, Krupskaya Street, Smolensk 214019, Russian Federation